Pyxis Share Price

Pyxis Share Price

NASDAQ: PYXS | Micro Cap | Healthcare
$1.42
-$0.01 (-0.35%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Pyxis Stock Performance

Open
$1.46
Prev. Close
$1.43
Circuit Range
N/A
Day Range
$1.38 - $1.46
Year Range
$1.03 - $5.55
Volume
54,280
Average Traded
$1.41

Pyxis Share Price Today

As of 19 November 2026, Pyxis Oncology, Inc.'s share price is $1.42. The stock opened at $1.46, compared to its previous close of $1.43. During today's trading session, Pyxis Oncology, Inc.'s share price traded between $1.38 and $1.46, with an average price of $1.42. Over the past 52 weeks, the stock has recorded a high of $5.55 and a low of $1.03. In terms of performance, Pyxis Oncology, Inc.'s share price has declined by 21.33% over the last six months and is down 72.53% on a year-on-year basis.

Pyxis Share Price Chart

Line chart of the Pyxis price trend over the selected period. The price fell overall, ranging from 1.39 to 1.46, ending at 1.42.
$1.38$1.46
L
Show Current Price
H

Pyxis Stock Fundamentals & Key Indicators

Market Cap
$88.24M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.72
Revenue (TTM)
$13.86B
Return On Equity (TTM)
-209.85%
Profit Margin
-574.46%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-10.33%

Pyxis Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$11.04$0.00$0.00$0.00
Net Profit-$18.11-$23.27-$25.35-$19.98
Net Profit Margin-164.04%N/AN/AN/A
Income ChangeN/A-28.49%-8.94%21.18%

Pyxis Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$16.15$13.86
Net Profit-$120.72-$73.79-$77.33-$79.62
Net Profit MarginN/AN/A-478.82%-574.46%
Income ChangeN/A38.88%-4.80%-2.96%

Pyxis Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets19.4224.7449.1224.77
Current Assets72.11132.44124.6186.61
Total Assets91.52157.18173.73211.38
Non Current Liabilities16.9818.7522.2618.92
Current Liabilities21.1317.6825.7631.63
Total Liabilities38.1136.4348.0250.56
Shareholders' Equity53.41120.75125.7160.82

Pyxis Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-63.5-57.67-70.71-89.34
Investing58.868.16-104.85-6.4
Financing0.5959.335.930.18

About Pyxis

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.

Pyxis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.82
$1.41
-22.74%
Oct 2026
$2.27
$1.82
-21.34%
Sep 2026
$3.27
$2.32
-30.54%
Aug 2026
$2.79
$3.34
+26.52%
Jul 2026
$3.06
$2.64
-12.00%
Jun 2026
$1.81
$3.00
+66.20%
May 2026
$1.69
$1.80
+5.87%
Apr 2026
$1.52
$1.71
+16.78%
Mar 2026
$1.40
$1.46
-1.02%
Feb 2026
$1.49
$1.48
+1.03%
Jan 2026
$1.14
$1.46
+26.41%
Dec 2025
$5.10
$1.16
-77.66%

Pyxis Share Price FAQs